Precision medicine for patients with advanced biliary tract cancers: Updated results from the prospective MOSCATO trial

被引：0
|
作者：
Verlingue, L. [1 ]
Malka, D. [2 ]
Allorant, A. [3 ]
Massard, C. [1 ]
Ferte, C. [4 ]
Lacroix, L. [5 ]
Rouleau, E. [6 ]
Auger, N. [7 ]
Delahousse, J. [8 ]
Sun, R. [9 ]
de Baere, T. [10 ]
Tselikas, L. [11 ]
Ba, B. [12 ]
Scoazec, J-Y. [13 ]
Michiels, S. [14 ]
Boige, V. [15 ]
Ducreux, M. [15 ]
Soria, J-C.
Hollebecque, A. [1 ]
机构：
[1] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[2] Inst Cancerol Gustave Roussy, Digest Oncol, Villejuif, France
[3] Gustave Roussy, Biostatist, Villejuif, France
[4] Gustave Roussy, Head & Neck, Villejuif, France
[5] Inst Gustave Roussy, BMO, Villejuif, France
[6] Gustave Roussy, Dept Biol & Pathol Med, Villejuif, France
[7] Gustave Roussy Canc Campus Grand Paris, Biol & Pathol Dept, Villejuif, France
[8] Inst Cancerol Gustave Roussy, Pharmacol, Villejuif, France
[9] Inst Gustave Roussy, Radiotherapy Dept, Radi INSERM U1030, Villejuif, France
[10] Inst Gustave Roussy, Radiol, Villejuif, France
[11] Gustave Roussy, Radiol, Villejuif, France
[12] Inst Cancerol Gustave Roussy, Radiol, Villejuif, France
[13] Gustave Roussy Inst, Pathol, Villejuif, France
[14] Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France
[15] Inst Gustave Roussy, Gastrointestinal Unit, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
726P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial
    Houessinon, A.
    Verlingue, L.
    Hollebecque, A.
    Even, C.
    Lacroix, L.
    Postel-Vinay, S.
    Varga, A.
    El Dakdouki, Y.
    Balheda, R.
    Michot, J-M.
    Gazzah, A.
    Marabelle, A.
    Michiels, S.
    Rouleau, E.
    Breuskin, I.
    de Baere, T.
    Angevin, E.
    Scoazec, J-Y.
    Soria, J-C.
    Massard, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Overall survival results of the single-institution molecular screening MOSCATO trial in hard-to-treat advanced cancers
    El Dakdouki, Yolla
    Allorant, Adrien
    Verlingue, Loic
    Lacroix, Ludovic
    Rouleau, Etienne
    Auger, Nathalie
    Michiels, Stefan
    Debaere, Thierry
    Andre, Fabrice
    Vassal, Gilles
    Jovelet, Cecile
    Tselikas, Lambros
    Soria, Jean-Charles
    Hollebecque, Antoine
    Massard, Christophe
    CANCER RESEARCH, 2018, 78 (13)
  • [33] High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
    Massard, Christophe
    Michiels, Stefan
    Ferte, Charles
    Le Deley, Marie-Cecile
    Lacroix, Ludovic
    Hollebecque, Antoine
    Verlingue, Loic
    Ileana, Ecaterina
    Rosellini, Silvia
    Ammari, Samy
    Ngo-Camus, Maud
    Bahleda, Rastislav
    Gazzah, Anas
    Varga, Andrea
    Postel-Vinay, Sophie
    Loriot, Yohann
    Even, Caroline
    Breuskin, Ingrid
    Auger, Nathalie
    Job, Bastien
    De Baere, Thierry
    Deschamps, Frederic
    Vielh, Philippe
    Scoazec, Jean-Yves
    Lazar, Vladimir
    Richon, Catherine
    Ribrag, Vincent
    Deutsch, Eric
    Angevin, Eric
    Vassal, Gilles
    Eggermont, Alexander
    Andre, Fabrice
    Soria, Jean-Charles
    CANCER DISCOVERY, 2017, 7 (06) : 586 - 595
  • [34] Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
    Bengala, C.
    Bertolini, F.
    Malavasi, N.
    Boni, C.
    Aitini, E.
    Dealis, C.
    Zironi, S.
    Depenni, R.
    Fontana, A.
    Del Giovane, C.
    Luppi, G.
    Conte, P.
    BRITISH JOURNAL OF CANCER, 2010, 102 (01) : 68 - 72
  • [35] Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
    C Bengala
    F Bertolini
    N Malavasi
    C Boni
    E Aitini
    C Dealis
    S Zironi
    R Depenni
    A Fontana
    C Del Giovane
    G Luppi
    P Conte
    British Journal of Cancer, 2010, 102 : 68 - 72
  • [36] Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
    Ikeda, Masafumi
    Ioka, Tatsuya
    Fukutomi, Akira
    Morizane, Chigusa
    Kasuga, Akiyoshi
    Takahashi, Hideaki
    Todaka, Akiko
    Okusaka, Takuji
    Creasy, Caretha L.
    Gorman, Shelby
    Felitsky, Daniel J.
    Kobayashi, Mikiro
    Zhang, Fanghong
    Furuse, Junji
    CANCER SCIENCE, 2018, 109 (01): : 215 - 224
  • [37] A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC).
    Kim, Richard D.
    Kim, Dae Won
    Alese, Olatunji B.
    Li, Daneng
    Shah, Neal
    Schell, Michael J.
    Zhou, Jun Min
    Chung, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
    Jonathan D Mizrahi
    Valerie Gunchick
    Kabir Mody
    Lianchun Xiao
    Phanikeerthi Surapaneni
    Rachna T Shroff
    Vaibhav Sahai
    World Journal of Gastrointestinal Oncology, 2020, (01) : 83 - 91
  • [39] Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
    Mizrahi, Jonathan D.
    Gunchick, Valerie
    Mody, Kabir
    Xiao, Lianchun
    Surapaneni, Phanikeerthi
    Shroff, Rachna T.
    Sahai, Vaibhav
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (01) : 83 - 91
  • [40] Molecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial
    Vuagnat, P.
    Baldini, C.
    Verlingue, L.
    Romano, P. Martin
    Varga, A.
    Hollebecque, A.
    Postel-Vinay, S.
    Gazzah, A.
    Bahleda, R.
    Marabelle, A.
    Ribrag, V.
    Champiat, S.
    Michot, J-M.
    Soria, J-C.
    Massard, C.
    ANNALS OF ONCOLOGY, 2018, 29
12345